Literature DB >> 1900647

Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells.

S Yoshimoto1, Y Ishizaki, T Sasaki, S Murota.   

Abstract

We have previously reported the production of endothelin, a potent vasoconstrictor peptide, by porcine cerebral microvessel endothelia and suggested its important role in the regulation of local blood flow within the brain. In our present study, radioimmunoassay with anti-porcine endothelin antiserum revealed that endothelin, produced by cerebral microvessel endothelia grown on a filter, is released mainly to the basement membrane side, not the vascular lumen side. This finding suggests that endothelin constricts arterioles locally where it is produced by endothelia. We also found that cerebral microvessel endothelia produce less endothelin under low oxygen pressure and more endothelin under low carbon dioxide pressure. Our results suggest that endothelin has a role in the regulation of cerebral blood flow in response to oxygen and carbon dioxide pressure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900647     DOI: 10.1161/01.str.22.3.378

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  Role of endothelin in the control of peripheral vascular tone in human hypertension.

Authors:  S Taddei; A Virdis; L Ghiadoni; I Sudano; A Magagna; A Salvetti
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 3.  The vascular endothelin system in hypertension--recent patents and discoveries.

Authors:  Meri M Hynynen; Raouf A Khalil
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2006-01

4.  EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

Authors:  K M McCulloch; C C Docherty; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 5.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 6.  Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension.

Authors:  Raouf A Khalil
Journal:  Curr Mol Pharmacol       Date:  2011-11       Impact factor: 3.339

7.  Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension.

Authors:  M A Al-Omari; M Khaleghi; T H Mosley; N G Morgenthaler; J Struck; A Bergmann; I J Kullo
Journal:  J Hum Hypertens       Date:  2010-02-25       Impact factor: 3.012

8.  Endothelin-1 in idiopathic pulmonary fibrosis.

Authors:  M Uguccioni; L Pulsatelli; B Grigolo; A Facchini; L Fasano; C Cinti; M Fabbri; G Gasbarrini; R Meliconi
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

9.  Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.

Authors:  Neeraj Dhaun; Pajaree Lilitkarntakul; Iain M Macintyre; Eline Muilwijk; Neil R Johnston; David C Kluth; David J Webb; Jane Goddard
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

10.  Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.

Authors:  S P Gampenrieder; C Hufnagl; S Brechelmacher; F Huemer; H Hackl; G Rinnerthaler; F Romeder; C Monzo Fuentes; P Morre; C Hauser-Kronberger; B Mlineritsch; R Greil
Journal:  Pharmacogenomics J       Date:  2016-05-03       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.